L-carnitine is an endogenous HDAC inhibitor selectively inhibiting cancer cell growth in vivo and in vitro
Medical Considerations: Semaglutide or Tirzepatide, including micro-dose programs, cannot be prescribed and should not be purchased by individuals with a BMI under 25 (or under 20 for micro-dosing), an eating disorder, diabetes, gallbladder disease, history of drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer or a family history of it, diabetic retinopathy, multiple endocrine neoplasia type 2, or those who are pregnant, breastfeeding, or planning to become pregnant
Does Losing Muscle Change Weight While on Ozempic
In the SURPASS-CVOT trial, which compared it with another GLP-1 medication (dulaglutide) rather than a placebo, tirzepatide was non-inferior for major cardiovascular events and reduced the risk of death from any cause by 16%